Alumis Inc share price logo

Alumis Inc Share Price

NASDAQ: ALMS

Small Cap

$10.97

-0.43

(-3.77%)

as on

Alumis Inc Stock Performance

as on December 27, 2025 at 2:29 am IST

  • Day's Low

    Day's High

    $10.83
    $11.34
    downward going graph

    1.28%

    Downside

    3.37%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.76
    $12.44
    downward going graph

    74.84%

    Downside

    13.40%

    Upside

    downward going graph

Alumis Inc share price movements today

Previous Close
$11.40
Open
$11.21
Volume
617.7K
Day's Low - High
$10.83 - $11.34
52 Week Low - High
$2.76 - $12.44

Alumis Inc Historical Returns

1 Month Return
+ 43.59 %
3 Month Return
+ 170.86 %
1 Year Return
+ 36.1 %
3 Year Return
0 %
5 Year Return
0 %

Alumis Inc Stock Fundamentals & Key Indicators

Check Alumis Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2B

EPS (TTM)

-2.88

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-66.88%

Alumis Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alumis Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Alumis Inc image
Alumis Inc
NA$1.2BNANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$37.9B402.34%-16.34-264.83%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$52.9B191.21%1431.041.36%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$118.7B97.43%32.5831.35%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$83.1B60.55%18.832.13%

Stock Returns calculator for Alumis Inc Stock including INR - Dollar returns

The Alumis Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

Alumis Inc investment value today

Current value as on today

₹1,41,068

Returns

₹41,068

(+41.07%)

Returns from Alumis Inc Stock

₹36,104 (+36.1%)

Dollar Returns*

₹4,964 (+4.96%)

Alumis Inc Stock’s Investor Sentiment and Interest

Search interest for Alumis Inc Stock has increased by 196% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:196% versus previous 30 day period

Alumis Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
3
17
2
2
Gross Profit
0
0
0
0
0
0
0
17
2
2
Operating Income
-37
-43
-40
-47
-56
-98
-98
-101
-140
-115
EBITDA
-37
-43
-39
-46
-55
-97
-93
-100
-119
-109
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
-
-
0
Income Before Tax
-36
-43
-39
-49
-56
-93
-94
-98
50
-110
Income Tax Expense
-
-
-
-
-
-
-
-
-8
-
Net Income
-36
-43
-39
-49
-56
-93
-94
-98
59
-110
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-3121.18%
-569.11%
2225.09%
-5360.70%

Alumis Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
Gross Profit
0
-1
-3
Operating Income
-113
-158
-300
EBITDA
-113
-156
-297
Interest Expense
-
-
-
Depreciation
0
1
3
Income Before Tax
-111
-154
-294
Income Tax Expense
-
-
-
Net Income
-111
-154
-294
Net Profit Margin
0.00%
0.00%
0.00%

Alumis Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-43
-39
-49
-56
-93
-94
-98
59
-110
Operating Cash Flow
-33
-33
-44
-52
-83
-74
-80
-106
-110
Investing Cash Flow
7
-4
-18
-32
-93
30
39
129
24
Financing Cash Flow
0
29
129
128
235
0
-
0
-
Change in Cash
-25
-8
66
43
58
-43
-40
23
-86

Alumis Inc Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Net Income
-154
-294
Operating Cash Flow
-129
-255
Investing Cash Flow
60
-113
Financing Cash Flow
89
492
Change in Cash
20
123

Insights on Alumis Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, ALMS stock has moved up by 170.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 155.5% return, outperforming this stock by 119.4%

About Alumis Inc

Alumis Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing next-generation targeted therapies with the potential to significantly improve patient health and outcomes across a range of immune-mediated diseases. Leveraging its proprietary data analytics platform and precision approach, the Company is developing a pipeline of oral tyrosine kinase 2 (TYK2) inhibitors, consisting of ESK-001 for the treatment of systemic immune-mediated disorders, such as moderate-to-severe plaque psoriasis and systemic lupus erythematosus, and A-005 for the treatment of neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Parkinson’s Disease. In addition, its pipeline also includes lonigutamab, a subcutaneously delivered anti-insulin-like growth factor 1 receptor therapy for the treatment of thyroid eye disease, as well as several preclinical programs identified through this precision approach.
OrganisationAlumis Inc
Headquarters280 East Grand Avenue, South San Francisco, CA, United States, 94080
CEOMr. Martin Babler Ph.D.
E-voting on sharesClick here to vote

Key Management of Alumis Inc

Name

Title

Mr. Philip Nunn Ph.D.

Senior VP of Pharmacology & Project Team Leader

Dr. Jorn Drappa M.D., Ph.D.

Chief Medical Officer & Head of Research and Development

Mr. Mark Bradley

Chief Development Officer

Mr. Kolbot By Ph.D.

Senior VP & Head of Technical Operations

Mr. Martin Babler Ph.D.

President, CEO & Chairman

Mr. John R. Schroer C.F.A.

Chief Financial Officer

Ms. Claire Langrish Ph.D.

Senior VP & Head of Immunology and Translational Science

Dr. David M. Goldstein Ph.D.

Chief Scientific Officer

Mr. Roy C. Hardiman J.D.

Chief Business & Strategy Officer

Ms. Sanam Pangali J.D.

Chief Legal Officer & Corporate Secretary

FAQs

What is Alumis Inc share price today?

Alumis Inc share price today is $10.97 as on at the close of the market. Alumis Inc share today touched a day high of $11.34 and a low of $10.83.

What is the 52 week high and 52 week low for Alumis Inc share?

Alumis Inc share touched a 52 week high of $12.44 on and a 52 week low of $2.76 on . Alumis Inc stock price today i.e. is closed at $10.97,which is 11.82% down from its 52 week high and 297.45% up from its 52 week low.

What is Alumis Inc's market capitalisation today?

Alumis Inc market capitalisation is $0.00T as on .

How to invest in Alumis Inc Stock (ALMS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alumis Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alumis Inc Shares that will get you 0.1367 shares as per Alumis Inc share price of $10.97 per share as on December 27, 2025 at 2:29 am IST.

What is the minimum amount required to buy Alumis Inc Stock (ALMS) from India?

Indian investors can start investing in Alumis Inc (ALMS) shares with as little as ₹89.746 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹897.46 in Alumis Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Alumis Inc share’s latest price of $10.97 as on December 27, 2025 at 2:29 am IST, you will get 0.9116 shares of Alumis Inc. Learn more about fractional shares .